This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2007.03.049v1 50/5/432    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dalal, D. Articles by Calkins, H. Search for Related Content PubMed PubMed Citation Articles by Dalal, D. Articles by Calkins, H. Related Collections Related Article

CLINICAL RESEARCH: HEART RHYTHM DISORDERS

Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland

Manuscript received December 20, 2006; revised manuscript received February 20, 2007, accepted March 20, 2007.

^_* Reprint requests and correspondence: Dr. Hugh Calkins, 600 North Wolfe Street, Carnegie 530, Baltimore, Maryland 21287 (Email: hcalkins{at}jhmi.edu).

Objectives: This study sought to evaluate the outcomes of radiofrequency catheter ablation (RFA) of ventricular tachycardia (VT) in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) patients. Particular focus was placed on defining the single-procedure efficacy over long-term follow-up.

Background: ARVD/C is an inherited cardiomyopathy characterized by VT and right ventricular dysfunction. Prior single-center studies have reported conflicting results concerning the efficacy of RFA of VT in ARVD/C patients.

Methods: The study population comprised 24 patients (age 36 ± 9 years, 11 male), enrolled in the Johns Hopkins ARVD registry, who underwent 1 or more RFA procedures for treatment of VT. Patients were followed up for 32 ± 36 months (range 1 day to 12 years). Recurrence was defined as the documentation of VT subsequent to the procedure.

Results: A total of 48 RFA procedures were performed using 3-dimensional electroanatomical (n = 10) or conventional (n = 38) mapping. Of these procedures, 22 (46%), 15 (31%), and 11 (23%) resulted in elimination of all inducible VTs, clinical VT but not all, and none of the inducible VTs, respectively. Forty (85%) procedures were followed by recurrence. The cumulative VT recurrence-free survival was 75%, 50%, and 25% after 1.5, 5, and 14 months, respectively. The cumulative VT recurrence-free survival did not differ by procedural success, mapping technique, or repetition of procedures. There was 1 procedure-related death.

Conclusions: Our study shows a high rate of recurrence in ARVD/C patients undergoing RFA of VT. This likely reflects the fact that ARVD/C is a diffuse cardiomyopathy with progressively evolving electrical substrate. Further studies are needed to define the precise role of RFA of VT in ARVD/C.

Abbreviations and Acronyms   ARVD/C = arrhythmogenic right ventricular dysplasia/cardiomyopathy   ICD = implantable cardioverter-defibrillator   RFA = radiofrequency catheter ablation   RV = right ventricle/ventricular   VT = ventricular tachycardia

Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2007 50: A28. [Full Text] [PDF]

This article has been cited by other articles:

				K. S. Hoffmayer, O. N. Machado, G. M. Marcus, Y. Yang, C. J. Johnson, S. Ermakov, E. Vittinghoff, U. Pandurangi, H. Calkins, D. Cannom, et al. Electrocardiographic Comparison of Ventricular Arrhythmias in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy and Right Ventricular Outflow Tract Tachycardia J. Am. Coll. Cardiol., August 16, 2011; 58(8): 831 - 838. [Abstract] [Full Text] [PDF]

				R. Bai, L. Di Biase, K. Shivkumar, P. Mohanty, R. Tung, P. Santangeli, L. C. Saenz, M. Vacca, A. Verma, Y. Khaykin, et al. Ablation of Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Arrhythmia-Free Survival After Endo-Epicardial Substrate Based Mapping and Ablation Circ Arrhythm Electrophysiol, August 1, 2011; 4(4): 478 - 485. [Abstract] [Full Text] [PDF]

				H. Calkins Use of Mouse Models to Evaluate Novel Therapeutic Approaches to Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy: The Future Is Now J. Am. Coll. Cardiol., February 8, 2011; 57(6): 751 - 752. [Full Text] [PDF]

				M. P. Riley, E. Zado, R. Bala, D. J. Callans, J. Cooper, S. Dixit, F. Garcia, E. P. Gerstenfeld, M. D. Hutchinson, D. Lin, et al. Lack of Uniform Progression of Endocardial Scar in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Ventricular Tachycardia Circ Arrhythm Electrophysiol, August 1, 2010; 3(4): 332 - 338. [Abstract] [Full Text] [PDF]

				D. T. Murphy, S. C. Shine, A. Cradock, J. M. Galvin, E. T. Keelan, and J. G. Murray Cardiac MRI in Arrhythmogenic Right Ventricular Cardiomyopathy Am. J. Roentgenol., April 1, 2010; 194(4): W299 - W306. [Abstract] [Full Text] [PDF]

				K.-H. Kuck Should Catheter Ablation be the Preferred Therapy for Reducing ICD Shocks?: Ventricular Tachycardia in Patients With an Implantable Defibrillator Warrants Catheter Ablation Circ Arrhythm Electrophysiol, December 1, 2009; 2(6): 713 - 720. [Full Text] [PDF]

				F. C. Garcia, V. Bazan, E. S. Zado, J. F. Ren, and F. E. Marchlinski Epicardial Substrate and Outcome With Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Circulation, August 4, 2009; 120(5): 366 - 375. [Abstract] [Full Text] [PDF]

				E. M. Aliot, W. G. Stevenson, J. M. Almendral-Garrote, F. Bogun, C. H. Calkins, E. Delacretaz, P. D. Bella, G. Hindricks, P. Jais, M. E. Josephson, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Europace, June 1, 2009; 11(6): 771 - 817. [Full Text] [PDF]

				D. Corrado, C. Basso, and G. Thiene Arrhythmogenic right ventricular cardiomyopathy: an update Heart, May 1, 2009; 95(9): 766 - 773. [Full Text] [PDF]